EAM Global Investors’s Axonics, Inc. Common Stock AXNX Stock Holding History

EAM Global Investors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-29,369	Closed	-$2.07M	–	246
2022 Q3	$2.07M	Buy	+29,369	New	+$2.03M	0.55%	61
2021 Q4	–	Sell	-17,016	Closed	-$1.11M	–	284
2021 Q3	$1.11M	Buy	+17,016	New	+$1.16M	0.26%	173
2019 Q4	–	Sell	-61,913	Closed	-$1.67M	–	154
2019 Q3	$1.67M	Hold	61,913	–	–	0.81%	53
2019 Q2	$2.54M	Hold	61,913	–	–	1.08%	19
2019 Q1	$1.48M	Buy	+61,913	New	+$1.12M	0.66%	75

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

EAM Global Investors's AXNX Position: Q4 2022 in Review

EAM Global Investors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2022, closing a stake of 29,369 shares — an estimated $2.07M sold.

EAM Global Investors first reported a position in AXNX in Q1 2019 and held it in 5 quarters. The position peaked at $2.54M in Q2 2019. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

EAM Global Investors reported no remaining Axonics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
EAM Global Investors sold 29,369 Axonics, Inc. Common Stock shares in Q4 2022, an estimated $2.07M.
EAM Global Investors first reported a position in Axonics, Inc. Common Stock in Q1 2019 and held it in 5 quarters.
EAM Global Investors's Axonics, Inc. Common Stock position peaked at $2.54M in Q2 2019.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on EAM Global Investors's 13F filing for Q4 2022, filed 14 Feb 2023.